TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ferring Pharmaceuticals A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,690,294
|
1,457,509
|
1,261,432 |
| Earnings before taxes |
98,972
|
86,235
|
63,945 |
| Total assets |
554,485
|
586,405
|
485,671 |
| Current assets |
318,097
|
328,564
|
215,513 |
| Current liabilities |
282,477
|
315,813
|
255,819 |
| Equity capital |
266,214
|
189,325
|
121,995 |
| - share capital |
500
|
500
|
500 |
| Employees (average) |
750
|
350
|
350 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.0%
|
32.3%
|
25.1% |
| Turnover per employee |
2,254
|
4,164
|
3,604 |
| Profit as a percentage of turnover |
5.9%
|
5.9%
|
5.1% |
| Return on assets (ROA) | |||
| Current ratio |
112.6%
|
104.0%
|
84.2% |
| Return on equity (ROE) |
37.2%
|
45.5%
|
52.4% |
| Change turnover |
232,785
|
196,077
|
255,964 |
| Change turnover % |
16%
|
16%
|
25% |
| Chg. No. of employees |
400
|
0
|
0 |
| Chg. No. of employees % |
114%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.